Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD CME Group Education AD Bank of England Statistics AD Investing.com Markets AD LSEG Data
Venues & MTFs

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

Trade Hub UK briefing (2026-10-06): (RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its… Primary source: original at Nasdaq Market Structure (nasdaq.com).

By Nasdaq Market Structure

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

(RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its European launch. Restylane, which was introduced as a hyaluronic acid injectable, has since expanded into a portfolio of produc

Read at source

Read also
  1. Tesla Just Delivered Excellent News, but Is the Stock a Buy?
  2. Malaysia Bourse May Add To Its Winnings On Tuesday
  3. Singapore Stock Market May Crack Resistance At 5,700 Points
  4. Nebius Has Been One of 2026's Best-Performing AI Cloud Stocks. Here's What $1,000 Invested Could Be Worth by 2030.
  5. Australian Market Trims Early Gains In Mid-market

Source: Nasdaq Market Structure